NeuBase Therapeutics, Inc.: Istoricul versiunilor

2 octombrie 2024

• actualăprec 08:372 octombrie 2024 08:37‎ 127.0.0.1 discuție‎ 1.168 de octeți +4‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 20:1518 septembrie 2024 20:15‎ Admin discuție contribuții‎ 1.164 de octeți +1.164‎ Pagină nouă: Pagina dedicata companiei NeuBase Therapeutics, Inc. listata cu simbolul US.NBSE ==Descriere companie== NeuBase Therapeutics, Inc. (https://www.neubasetherapeutics.com/) is a pre-clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The Company’s peptide-nucleic acid antisense oligonucleotide (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dy...